Action Abattis Bioceuticals (EM) - ATTBF

Abattis Bioceuticals Corporation (EM) (ATTBF) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,000001

( - )

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

160 775

0,000001 Fourchette du Jour 0,000001

0,000001 Plage de 52 semaines 0,0001

Cap du marché

476,054

Clôture Veille

0,000001

Ouverture

0,000001

Dernière Transaction

775

1.0E-6

Dernière heure de transaction

Volume financier

US$ 0

VWAP

0,000001

Volume moyen (3 m)

US$ 48 465

Actions en circulation

476 054 139

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0

Bénéfice par action (BPA)

-0,01

Chiffre d'affairess (LTM)

356,88k

Bénéfice net (LTM)

-3,04M

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid... Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. Show more

Secteur

Healthcare

Industrie

Pharmaceuticals

Site Web

www.abattis.com

Siège social

Vancouver, Canada

Fondé

1997

Abattis Bioceuticals Corporation (EM) est coté dans le secteur Healthcare de la OTC Markets avec le ticker ATTBF. Le dernier cours de clôture d'Abattis Bioceuticals (EM) était de US$0,00. Au cours de la dernière année, les actions de Abattis Bioceuticals (EM) ont été négociées dans une fourchette de prix de US$ 0,000001 à US$ 0,0001.

Abattis Bioceuticals (EM) compte actuellement 476 054 139 actions en circulation. La capitalisation boursière d'Abattis Bioceuticals (EM) est de US$476,05 . Abattis Bioceuticals (EM) a un ratio cours/bénéfice (ratio PE) de -0.00.

S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports

S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports PR Newswire NEW YORK, March 25...

ANALYST REPORTS ON COMPANIES ANNOUNCING GAME CHANGING DEVELOPMENTS

Burton, MI - October 02, 2014 - InvestorsHub NewsWire - Anavex Life Sciences Corp. (OTCQB: AVXL) is a clinical-stage biopharmaceutical...

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX®

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX® PR Newswire NEW YORK, July 11, 2014 NEW YORK, July 11, 2014 /PRNewswire/ -- OTC Markets...

Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

VANCOUVER,B.C., May 5, 2014 (GLOBE NEWSWIRE) -- A hundred and fifty years ago, Harry Barr's (President and CEO of Next Gen Metals) (CSE:N) (OTC...

Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project

Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project Sponsorship will fund completion of...

Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resist...

Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance PR...

Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea

Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea PR Newswire VANCOUVER, British Columbia, March 6, 2013...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	1.0E-6	1.0E-6	1.0E-6	27069	1.0E-6	CS
4	0	0	1.0E-6	1.0E-6	1.0E-6	34618	1.0E-6	CS
12	0	0	1.0E-6	0.0001	1.0E-6	35566	1.0E-6	CS
26	0	0	1.0E-6	0.0001	1.0E-6	76991	1.0E-6	CS
52	-9.0E-6	-90	1.0E-5	0.0001	1.0E-6	70708	1.18E-6	CS
156	0	0	1.0E-6	0.000134	1.0E-6	39348	1.16E-6	CS
260	-0.015499	-99.9935483871	0.0155	0.0175	1.0E-6	82798	0.00533788	CS

ATTBF - Frequently Asked Questions (FAQ)

What is the current Abattis Bioceuticals Corporation (EM) share price?

The current share price of Abattis Bioceuticals Corporation (EM) is US$ 0,000001

How many Abattis Bioceuticals Corporation (EM) shares are in issue?

Abattis Bioceuticals Corporation (EM) has 476 054 139 shares in issue

What is the market cap of Abattis Bioceuticals Corporation (EM)?

The market capitalisation of Abattis Bioceuticals Corporation (EM) is USD 476,05

What is the 1 year trading range for Abattis Bioceuticals Corporation (EM) share price?

Abattis Bioceuticals Corporation (EM) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year

What is the PE ratio of Abattis Bioceuticals Corporation (EM)?

The price to earnings ratio of Abattis Bioceuticals Corporation (EM) is -0

What is the cash to sales ratio of Abattis Bioceuticals Corporation (EM)?

The cash to sales ratio of Abattis Bioceuticals Corporation (EM) is 0

What is the registered address of Abattis Bioceuticals Corporation (EM)?

The registered address for Abattis Bioceuticals Corporation (EM) is 625 Howe Street, Vancouver, British Columbia, V6C 2M6

What is the Abattis Bioceuticals Corporation (EM) website address?

The website address for Abattis Bioceuticals Corporation (EM) is www.abattis.com

Which industry sector does Abattis Bioceuticals Corporation (EM) operate in?

Abattis Bioceuticals Corporation (EM) operates in the Pharmaceuticals sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Abattis Bioceuticals Corporation (EM) (ATTBF)

Abattis Bioceuticals Corporation (EM) (ATTBF) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Abattis Bioceuticals Corporation (EM)

ATTBF Dernières nouvelles

S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports

ANALYST REPORTS ON COMPANIES ANNOUNCING GAME CHANGING DEVELOPMENTS

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX®

Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project

Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resist...

Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea

ATTBF - Frequently Asked Questions (FAQ)

ATTBF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Abattis Bioceuticals Corporation (EM) (ATTBF)

Abattis Bioceuticals Corporation (EM) (ATTBF) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Abattis Bioceuticals Corporation (EM)

ATTBF Dernières nouvelles

S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports

ANALYST REPORTS ON COMPANIES ANNOUNCING GAME CHANGING DEVELOPMENTS

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX®

Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project

Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resist...

Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea

ATTBF - Frequently Asked Questions (FAQ)

ATTBF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités